Join Paid Clinical Trials for Depression in

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Depression

Top of Directory » All Categories » by Illness » Depression



  • Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

    Conditions:   Alcohol Dependence;   Bipolar Disorder;   Depression;   Mania;   Affective Psychosis
    Interventions:   Drug: Lamotrigine;   Drug: Placebo
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified November 2009
  • Depression Management at the Workplace

    Condition:   Depression
    Interventions:   Other: Depression Product Detailing;   Other: Depression HEDIS detailing
    Sponsors:   Florida State University;   Colorado Business Group on Health
    Recruiting - verified November 2009
  • Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion

    Conditions:   Branch Retinal Vein Occlusion;   Central Retinal Vein Occlusion;   Retinal Vein Occlusion;   Depression
    Intervention:   Drug: ranibizumab (Lucentis)
    Sponsors:   Retina Associates of Cleveland, Inc;   Genentech
    Recruiting - verified November 2009
  • Cardiac Denervation Surgery for Prevention of Ventricular Tachycardia

    Conditions:   Sudden Cardiac Death;   Ventricular Tachycardia;   Ventricular Fibrillation;   Ischemic Cardiomyopathy
    Interventions:   Procedure: Left cervicothoracic sympathectomy;   Drug: ICD and medical therapy only
    Sponsors:   University of California, Los Angeles;   Divison of Electrophysiology, CARE Hospital in Hyderabad, Andra Pradesh, India;   Department of Cardiology, University of Pavia, Italy;   Arrhythmia Associates, Holy Family Hospital, Mumbai, Maharashtra, India
    Not yet recruiting - verified November 2009
  • Treatment for Depressed Primary Care Patients

    Condition:   Depression
    Interventions:   Behavioral: Depression Care Management (DCM);   Behavioral: Enhanced Care
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified November 2009
  • A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]

    Condition:   HIV Infections
    Interventions:   Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
    Sponsors:   New York University;   St. Vincent's Medical Center
    Not yet recruiting - verified November 2009
  • A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Not yet recruiting - verified November 2009
  • Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.

    Conditions:   Obesity;   Gastric Emptying;   Anxiety;   Depression;   Panic Disorder
    Intervention:  
    Sponsors:   Medical University of South Carolina;   National Institutes of Health (NIH);   Society of Nuclear Medicine, Southeastern Chapter
    Recruiting - verified November 2009
  • Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

    Conditions:   Neurocognitive Impairment;   Acute Lymphoblastic Leukemia
    Intervention:   Other: Neurocognitive and behavioral evaluation
    Sponsors:   St. Jude Children's Research Hospital;   National Cancer Institute (NCI);   National Institute of Mental Health (NIMH)
    Not yet recruiting - verified November 2009
  • Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder

    Conditions:   Smoking Cessation;   Bipolar Disorder
    Interventions:   Drug: Varenicline (Chantix);   Drug: Placebo
    Sponsors:   University of Pittsburgh;   National Institute of Mental Health (NIMH);   Pfizer
    Not yet recruiting - verified November 2009
  • Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery

    Condition:   Ischemic Stroke
    Interventions:   Device: tDCS;   Device: Sham tDCS
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting - verified November 2009
  • Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder

    Condition:   Body Dysmorphic Disorder
    Intervention:   Behavioral: Cognitive-Behavioral Therapy
    Sponsor:   Massachusetts General Hospital
    Recruiting - verified October 2009
  • Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder

    Condition:   Posttraumatic Stress Disorder (PTSD)
    Interventions:   Drug: orvepitant;   Other: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • An Investigation of the Antidepressant Effects of a Low-Trapping Mixed NR2A/2B Antagonist in Treatment-Resistant Major Depression

    Condition:   Major Depression
    Intervention:   Drug: AZD6765
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified September 2009
  • Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

    Conditions:   Traumatic Brain Injury;   Attention Deficit Disorder
    Interventions:   Drug: Vyvanse;   Procedure: fMRI
    Sponsors:   Vanderbilt University;   Shire Pharmaceutical Development
    Recruiting - verified October 2009
  • SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: SPD489 (Lisdexamfetamine dimesylate);   Drug: Matching placebo
    Sponsor:   Shire Pharmaceutical Development
    Recruiting - verified November 2009
  • Clinical Study to Test a New Drug to Treat Major Depression

    Condition:   Major Depressive Disorder (MDD)
    Interventions:   Drug: GW856653;   Other: Placebo;   Drug: GW856653
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Reducing Tobacco Related Health Disparities

    Conditions:   Smoking Cessation;   Smoking
    Interventions:   Behavioral: Standard Treatment (ST);   Behavioral: Telephone Counseling
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009
  • Safety and Efficacy of F2695 SR in Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: F2695 SR;   Drug: F2695 SR;   Drug: F2695 SR;   Drug: Placebo
    Sponsor:   Forest Laboratories
    Recruiting - verified November 2009
  • A Study for Adult Patients With Fibromyalgia

    Conditions:   Fibromyalgia, Primary;   Fibromyalgia, Secondary
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • Depression Outcomes Study of Exercise

    Condition:   Major Depressive Disorder (MDD)
    Interventions:   Other: Public Health Dose of Exercise (PHD);   Other: Low Dose Exercise (LD)
    Sponsors:   Klein Buendel, Inc.;   University of Colorado at Denver and Health Sciences Center
    Recruiting - verified August 2009
  • A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

    Condition:   Attention Deficit Hyperactivity Disorder
    Intervention:   Drug: LY2216684
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • A Study in Relapse Prevention of Treatment-resistant Depression

    Condition:   Treatment Resistant Depression
    Interventions:   Drug: Olanzapine and Fluoxetine combination;   Drug: Fluoxetine
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • Support Needs and Preferences of Family Caregivers of Lung Cancer Patients

    Condition:   Lung Cancer
    Intervention:   Behavioral: Questionnaires/Interviews
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   Queens Cancer Center;   Michigan State University;   National Cancer Institute (NCI)
    Recruiting - verified November 2009
  • The Experience of Uncertainty in Parents of Children With an Undiagnosed Medical Condition

    Condition:   Multiple Abnormalities
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting - verified July 2009
  • A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)

    Conditions:   Bipolar Disorder;   Depression
    Intervention:   Drug: PF-04455242
    Sponsor:   Pfizer
    Recruiting - verified October 2009
  • Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Device: Brainsway H-Coil Deep TMS System;   Device: Brainsway H-Coil Deep TMS System (Sham treatment)
    Sponsor:   Brainsway
    Recruiting - verified October 2009
  • A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

    Condition:   Attention Deficit Hyperactivity Disorder
    Interventions:   Drug: LY2216684;   Drug: Methylphenidate;   Drug: Placebo (tablet);   Drug: Placebo (capsule)
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • Eslicarbazepine Acetate Monotherapy Long Term Study

    Condition:   Epilepsy
    Intervention:   Drug: Eslicarbazepine acetate
    Sponsor:   Sepracor, Inc.
    Recruiting - verified October 2009
  • MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women

    Conditions:   Hot Flashes;   Menopause;   Vasomotor Symptoms
    Interventions:   Drug: Escitalopram;   Other: Placebo
    Sponsors:   Fred Hutchinson Cancer Research Center;   National Institute on Aging (NIA);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Center for Complementary and Alternative Medicine (NCCAM);   Office of Research on Women's Health (ORWH)
    Recruiting - verified November 2009
  • Randomized Withdrawal Study of Desvenlafaxine Succinate Sustained Release in Outpatients With Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Desvenlafaxine succinate sustained release Dose A;   Drug: Placebo
    Sponsor:   Wyeth
    Recruiting - verified November 2009
  • Oxytocin or 3-[(2,4-Dimethoxy) Benzylidene] Anabaseine (DMXB-A) Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: Oxytocin;   Drug: DMXB-A or placebo DMXB-A;   Drug: Placebo
    Sponsor:   University of Maryland
    Not yet recruiting - verified November 2009
  • Fatigue in Healthy Individuals

    Conditions:   Healthy Volunteer;   Fatigue;   Depression
    Intervention:  
    Sponsor:   National Institute of Nursing Research (NINR)
    Recruiting - verified April 2009
  • A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

    Condition:   Depression
    Interventions:   Other: Placebo;   Drug: orvepitant
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

    Condition:   Depression
    Interventions:   Drug: orvepitant;   Other: placebo
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis

    Conditions:   Psoriasis;   Atopic Dermatitis;   Healthy Dermatology Patients
    Intervention:   Other: Vital signs, height, weight, body mass index (BMI) calculation, waist circumference.
    Sponsor:   Northwestern University
    Recruiting - verified November 2009
  • Study Evaluating Desvenlafaxine Succinate Sustained Release in Adults With Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Desvenlafaxine Succinate Sustained-Release;   Drug: placebo
    Sponsor:   Wyeth
    Recruiting - verified November 2009
  • Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

    Condition:   Epilepsy With Simple or Complex Partial Onset Seizures
    Interventions:   Drug: Eslicarbazepine acetate;   Drug: Eslicarbazepine acetate
    Sponsor:   Sepracor, Inc.
    Recruiting - verified October 2009
  • Combination Pain Therapy in HIV Neuropathy

    Conditions:   HIV Infections;   Peripheral Neuropathy
    Interventions:   Drug: Duloxetine;   Drug: Duloxetine placebo;   Drug: Methadone;   Drug: Methadone placebo
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified May 2009
  • A Comprehensive Disease Management Program for Medically-Complex Substance Users

    Condition:   Substance-related Disorder
    Interventions:   Behavioral: Contingency Management;   Other: Case management
    Sponsors:   Johns Hopkins University;   Johns Hopkins Health Care;   Johns Hopkins Community Physicians
    Recruiting - verified November 2009
  • Safety and Efficacy of Caripazine As Adjunctive Therapy In Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Antidepressant + placebo;   Drug: Antidepressant + cariprazine (0.1-0.3 mg/day);   Drug: Antidepressant + cariprazine (1-2 mg/d)
    Sponsors:   Forest Laboratories;   Gedeon Richter Ltd.
    Recruiting - verified November 2009
  • Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

    Condition:   Bipolar Depression
    Interventions:   Drug: cariprazine;   Drug: cariprazine;   Drug: placebo
    Sponsors:   Forest Laboratories;   Gedeon Richter Ltd.
    Recruiting - verified October 2009
  • A Study in the Treatment of Children and Adolescents With Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: duloxetine;   Drug: Placebo;   Drug: fluoxetine
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

    Condition:   Bipolar Depression
    Interventions:   Drug: Olanzapine Fluoxetine Combination;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • National Children's Health Study

    Conditions:   Asthma;   Diabetes;   Obesity;   Premature Birth;   Autistic Disorder
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified October 2009
  • Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: LY451395;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009
  • Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: AQW051;   Drug: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009
  • Study of Medical Treatment for Methamphetamine Addiction

    Conditions:   Methamphetamine;   Amphetamine Dependence;   Pharmacogenetics;   Methamphetamine Dependence;   Substance Abuse
    Intervention:   Drug: Bupropion
    Sponsors:   National Institute on Drug Abuse (NIDA);   University of California, Los Angeles
    Recruiting - verified November 2009
  • Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

    Condition:   Advanced Cancer
    Intervention:   Drug: Remeron
    Sponsor:   University of New Mexico
    Recruiting - verified November 2009
  • The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study

    Conditions:   Cancer;   HIV Infections
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified October 2008
    • Menu
    Find Paid Clinical Trials